<DOC>
	<DOCNO>NCT01688518</DOCNO>
	<brief_summary>This randomize , single-blind , active-controlled , two-period crossover study adult volunteer compare duration depth anesthesia Synera速 Lidoderm速 patch apply 30 minute 4 hour . The study include Screening Visit , two Treatment Periods , Follow-Up Phone Contact .</brief_summary>
	<brief_title>Evaluation Depth Duration Anesthesia From Heated Lidocaine/Tetracaine ( Synera速 ) Patches Compared With 5 % Lidocaine ( Lidoderm速 ) Patches Applied Healthy Adult Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Anesthetics</mesh_term>
	<mesh_term>Lidocaine</mesh_term>
	<mesh_term>Tetracaine</mesh_term>
	<criteria>Inclusion : 1 . Subject male female 1860 year age , inclusive . 2 . Subject judge Investigator generally good health screen base upon result medical history , physical examination , clinical laboratory profile , 12lead electrocardiogram ( ECG ) . 3 . Subject willing refrain use local topical preparation volar aspect forearm 24 hour prior site visit . 4 . Subject normal , intact skin bilaterally antecubital area . 5 . If female , must nonchildbearing potential ( define postmenopausal least 1 year surgically sterile [ bilateral tubal ligation , bilateral oophorectomy hysterectomy ] ) must use adequate contraception ( practice one follow method birth control ) : Total abstinence sexual intercourse ( minimum one complete menstrual cycle study entry ) , A vasectomized partner , Contraceptives ( oral , parenteral , transdermal ) 3 consecutive month prior test product administration , Intrauterine device ( IUD ) , Doublebarrier method ( condom , sponge , diaphragm , vaginal ring spermicidal jelly cream ) . 6 . If female , must negative urine pregnancy test Screening checkin Treatment Period . 7 . Subject willing blindfold study agree abide study restriction comply study procedure . 8 . Able fluently speak understand English able provide meaningful write informed consent study . Exclusion : 1 . Subject clinically significant ECG abnormality screen . 2 . Subject currently receive class I , II , III antiarrhythmic agent . 3 . Subject use overthecounter ( OTC ) prescription analgesic within 24 hour prior either study period . 4 . Subject know allergy history significant adverse reaction component treatment related compound . 5 . Subject history active use abuse illicit drug substance alcohol abuse . 6 . Subject positive urine test result drug abuse positive ethanol breath test Screening Visit checkin Treatment Visit 1 . 7 . Subject active dermatological disease origin may interfere ability participate . 8 . Subject denude broken skin either forearm . 9 . Subject history unstable peripheral/vascular disease and/or hypertensive vascular disease .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Evaluation</keyword>
	<keyword>Depth Duration</keyword>
	<keyword>Anesthesia</keyword>
</DOC>